Status:
COMPLETED
Influence of Simvastatin on Apolipoprotein B-100 (apoB-100) Secretion
Lead Sponsor:
University Hospital, Bonn
Conditions:
Hypercholesterolemia
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
3-Hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins) decrease apolipoprotein B-100-containing lipoproteins by increasing their fractional catabolic rates through low-density lipoprotei...
Detailed Description
3-Hydroxy-3 methylglutaryl (HMG) coenzyme A-reductase inhibitors (statins) have an established role in the treatment of hypercholesterolemia. Their efficacy in reducing cardiovascular morbidity and mo...
Eligibility Criteria
Inclusion
- Hypercholesterolemia
Exclusion
- Obesity
- Treatment with lipid-lowering drugs
Key Trial Info
Start Date :
November 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2000
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00905541
Start Date
November 1 1998
End Date
March 1 2000
Last Update
May 20 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bonn
Bonn, Germany